• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4617662)   Today's Articles (2846)   Subscriber (49401)
For: Ohkura N, Hagihara Y, Yoshimura T, Goto Y, Kato H. Plasmin Can Reduce the Function of Human β2Glycoprotein I by Cleaving Domain V Into a Nicked Form. Blood 1998;91:4173-9. [DOI: 10.1182/blood.v91.11.4173] [Citation(s) in RCA: 38] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
Number Cited by Other Article(s)
1
Phinney NZ, Huang X, Toombs JE, Brekken RA. Development of betabodies: the next generation of phosphatidylserine targeting agents. J Biol Chem 2024:107681. [PMID: 39159812 DOI: 10.1016/j.jbc.2024.107681] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2024] [Revised: 06/09/2024] [Accepted: 08/02/2024] [Indexed: 08/21/2024]  Open
2
Giannakopoulos B, Krilis SA. Domain 5 of Beta 2 glycoprotein I: Friend or foe in health? Context matters. Clin Immunol 2024;265:110282. [PMID: 38917928 DOI: 10.1016/j.clim.2024.110282] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2023] [Revised: 06/03/2024] [Accepted: 06/05/2024] [Indexed: 06/27/2024]
3
Hasdemir HS, Pozzi N, Tajkhorshid E. Atomistic characterization of β2-glycoprotein I domain V interaction with anionic membranes. J Thromb Haemost 2024:S1538-7836(24)00427-6. [PMID: 39047943 DOI: 10.1016/j.jtha.2024.07.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2024] [Revised: 06/18/2024] [Accepted: 07/01/2024] [Indexed: 07/27/2024]
4
Periodic bilayer organization in the complexes of Beta-2 Glycoprotein I with anionic lipid membranes. Colloids Surf B Biointerfaces 2021;208:112118. [PMID: 34547703 DOI: 10.1016/j.colsurfb.2021.112118] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2021] [Revised: 09/04/2021] [Accepted: 09/13/2021] [Indexed: 11/20/2022]
5
Smalley H, Rowe JM, Nieto F, Zeledon J, Pollard K, Tomich JM, Fleming SD. Beta2 glycoprotein I-derived therapeutic peptides induce sFlt-1 secretion to reduce melanoma vascularity and growth. Cancer Lett 2020;495:66-75. [PMID: 32891714 PMCID: PMC7899169 DOI: 10.1016/j.canlet.2020.08.039] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2020] [Revised: 07/11/2020] [Accepted: 08/31/2020] [Indexed: 12/15/2022]
6
Ruben E, Planer W, Chinnaraj M, Chen Z, Zuo X, Pengo V, De Filippis V, Alluri RK, McCrae KR, Macor P, Tedesco F, Pozzi N. The J-elongated conformation of β2-glycoprotein I predominates in solution: implications for our understanding of antiphospholipid syndrome. J Biol Chem 2020;295:10794-10806. [PMID: 32518155 PMCID: PMC7397106 DOI: 10.1074/jbc.ra120.013939] [Citation(s) in RCA: 21] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2020] [Revised: 06/06/2020] [Indexed: 01/07/2023]  Open
7
Mutants of β2-glycoprotein I: Their features and potent applications. Best Pract Res Clin Rheumatol 2018;32:572-590. [DOI: 10.1016/j.berh.2019.01.007] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
8
Ağar Ç, de Groot P, Marquart JA, Meijers J. Evolutionary conservation of the lipopolysaccharide binding site of β2-glycoprotein I. Thromb Haemost 2017;106:1069-75. [DOI: 10.1160/th11-05-0333] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2011] [Accepted: 08/01/2011] [Indexed: 11/05/2022]
9
Krilis SA, Giannakopoulos B. Laboratory methods to detect antiphospholipid antibodies. HEMATOLOGY. AMERICAN SOCIETY OF HEMATOLOGY. EDUCATION PROGRAM 2014;2014:321-328. [PMID: 25696873 DOI: 10.1182/asheducation-2014.1.321] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
10
Conformation of beta2glycoprotein I and its effect on coagulation. Thromb Res 2012;130 Suppl 1:S33-6. [PMID: 22925530 DOI: 10.1016/j.thromres.2012.08.269] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
11
Reed JH, Clancy RM, Purcell AW, Kim MY, Gordon TP, Buyon JP. β2-glycoprotein I and protection from anti-SSA/Ro60-associated cardiac manifestations of neonatal lupus. THE JOURNAL OF IMMUNOLOGY 2011;187:520-6. [PMID: 21602492 DOI: 10.4049/jimmunol.1100122] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
12
Matsuura E, Shen L, Matsunami Y, Quan N, Makarova M, Geske FJ, Boisen M, Yasuda S, Kobayashi K, Lopez LR. Pathophysiology of β2-glycoprotein I in antiphospholipid syndrome. Lupus 2010;19:379-84. [DOI: 10.1177/0961203310361352] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
13
Bu C, Gao L, Xie W, Zhang J, He Y, Cai G, McCrae KR. beta2-glycoprotein i is a cofactor for tissue plasminogen activator-mediated plasminogen activation. ACTA ACUST UNITED AC 2009;60:559-68. [PMID: 19180513 DOI: 10.1002/art.24262] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
14
Rahgozar S, Giannakopoulos B, Yan X, Wei J, Cheng Qi J, Gemmell R, Krilis SA. Beta2-glycoprotein I protects thrombin from inhibition by heparin cofactor II: Potentiation of this effect in the presence of anti-β2-glycoprotein I autoantibodies. ACTA ACUST UNITED AC 2008;58:1146-55. [DOI: 10.1002/art.23387] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
15
Chapter 8 Interactions of Phospholipid Binding Proteins with Negatively Charged Membranes. ACTA ACUST UNITED AC 2008. [DOI: 10.1016/s1554-4516(08)00208-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register]
16
Sakai T, Balasubramanian K, Maiti S, Halder JB, Schroit AJ. Plasmin-cleaved beta-2-glycoprotein 1 is an inhibitor of angiogenesis. THE AMERICAN JOURNAL OF PATHOLOGY 2007;171:1659-69. [PMID: 17872974 PMCID: PMC2043526 DOI: 10.2353/ajpath.2007.070146] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
17
Rahgozar S, Yang Q, Giannakopoulos B, Yan X, Miyakis S, Krilis SA. Beta2-glycoprotein I binds thrombin via exosite I and exosite II: anti-beta2-glycoprotein I antibodies potentiate the inhibitory effect of beta2-glycoprotein I on thrombin-mediated factor XIa generation. ACTA ACUST UNITED AC 2007;56:605-13. [PMID: 17265495 DOI: 10.1002/art.22367] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
18
Beecken WDC, Engl T, Ringel EM, Camphausen K, Michaelis M, Jonas D, Folkman J, Shing Y, Blaheta RA. An endogenous inhibitor of angiogenesis derived from a transitional cell carcinoma: clipped beta2-glycoprotein-I. Ann Surg Oncol 2006;13:1241-51. [PMID: 16955386 DOI: 10.1245/s10434-006-9009-9] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2005] [Accepted: 12/13/2005] [Indexed: 11/18/2022]
19
Atsumi T, Amengual O, Yasuda S, Matsuura E, Koike T. Research around beta 2-glycoprotein I: a major target for antiphospholipid antibodies. Autoimmunity 2005;38:377-81. [PMID: 16227153 DOI: 10.1080/08916930500124312] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
20
Yasuda S, Atsumi T, Ieko M, Koike T. Beta2-glycoprotein I, anti-beta2-glycoprotein I, and fibrinolysis. Thromb Res 2005;114:461-5. [PMID: 15507279 DOI: 10.1016/j.thromres.2004.07.013] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2004] [Revised: 07/25/2004] [Accepted: 07/29/2004] [Indexed: 11/24/2022]
21
Shi T, Giannakopoulos B, Iverson GM, Cockerill KA, Linnik MD, Krilis SA. Domain V of β2-Glycoprotein I Binds Factor XI/XIa and Is Cleaved at Lys317-Thr318. J Biol Chem 2005;280:907-12. [PMID: 15522884 DOI: 10.1074/jbc.m410291200] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]  Open
22
Cockerill KA, Linnik MD, Iverson GM. Detection and characterization of B cell epitopes on β2-glycoprotein I. Clin Immunol 2004;112:129-35. [PMID: 15240155 DOI: 10.1016/j.clim.2004.02.011] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2004] [Accepted: 02/27/2004] [Indexed: 11/17/2022]
23
Miyakis S, Robertson SA, Krilis SA. Beta-2 glycoprotein I and its role in antiphospholipid syndrome—lessons from knockout mice. Clin Immunol 2004;112:136-43. [PMID: 15240156 DOI: 10.1016/j.clim.2004.02.014] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2004] [Accepted: 02/27/2004] [Indexed: 10/26/2022]
24
Shi T, Iverson GM, Qi JC, Cockerill KA, Linnik MD, Konecny P, Krilis SA. Beta 2-Glycoprotein I binds factor XI and inhibits its activation by thrombin and factor XIIa: loss of inhibition by clipped beta 2-glycoprotein I. Proc Natl Acad Sci U S A 2004;101:3939-44. [PMID: 15007174 PMCID: PMC374348 DOI: 10.1073/pnas.0400281101] [Citation(s) in RCA: 73] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]  Open
25
Miyakis S, Giannakopoulos B, Krilis SA. Beta 2 glycoprotein I-function in health and disease. Thromb Res 2004;114:335-46. [PMID: 15507263 DOI: 10.1016/j.thromres.2004.07.017] [Citation(s) in RCA: 81] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2004] [Revised: 07/18/2004] [Accepted: 07/23/2004] [Indexed: 10/26/2022]
26
Gao PJ, Piao YF, Liu XD, Qu LK, Shi Y, Wang XC, Yang HY. Studies on specific interaction of beta-2-glycoprotein I with HBsAg. World J Gastroenterol 2003;9:2114-6. [PMID: 12970918 PMCID: PMC4656686 DOI: 10.3748/wjg.v9.i9.2114] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]  Open
27
Reddel SW, Wang YX, Krilis SA. Anti-beta2-glycoprotein I autoantibodies require an antigen density threshold, consistent with divalent binding. Lupus 2003;12:37-45. [PMID: 12587825 DOI: 10.1191/0961203303lu280oa] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
28
Arnout J, Vermylen J. Current status and implications of autoimmune antiphospholipid antibodies in relation to thrombotic disease. J Thromb Haemost 2003;1:931-42. [PMID: 12871358 DOI: 10.1046/j.1538-7836.2003.00125.x] [Citation(s) in RCA: 79] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
29
Guerin J, Sheng Y, Reddel S, Iverson GM, Chapman MG, Krilis SA. Heparin inhibits the binding of beta 2-glycoprotein I to phospholipids and promotes the plasmin-mediated inactivation of this blood protein. Elucidation of the consequences of the two biological events in patients with the anti-phospholipid syndrome. J Biol Chem 2002;277:2644-9. [PMID: 11711550 DOI: 10.1074/jbc.m110176200] [Citation(s) in RCA: 64] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]  Open
30
Hoshino M, Hagihara Y, Nishii I, Yamazaki T, Kato H, Goto Y. Identification of the phospholipid-binding site of human beta(2)-glycoprotein I domain V by heteronuclear magnetic resonance. J Mol Biol 2000;304:927-39. [PMID: 11124037 DOI: 10.1006/jmbi.2000.4243] [Citation(s) in RCA: 38] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
31
Matsuura E, Koike T. Accelerated atheroma and anti-beta2-glycoprotein I antibodies. Lupus 2000;9:210-6. [PMID: 10805490 DOI: 10.1191/096120300678828262] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
32
Reddel SW, Krilis SA. Testing for and clinical significance of anticardiolipin antibodies. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY 1999;6:775-82. [PMID: 10548562 PMCID: PMC95774 DOI: 10.1128/cdli.6.6.775-782.1999] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
33
Arnout J, Vermylen J. Mechanism of action of beta2-glycoprotein I-dependent lupus anticoagulants. Lupus 1998;7 Suppl 2:S23-8. [PMID: 9814667 DOI: 10.1177/096120339800700206] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA